483
Family Fertility CenterFamily Fertility Center – FDA 483, Sep 14, 2021
Record Details
The FDA inspected Family Fertility Center, a human tissue reproductive establishment, and identified significant deficiencies in donor screening and testing practices. The firm failed to screen oocyte donors for Chlamydia trachomatis and did not test donors for relevant communicable disease agents, such as West Nile Virus. Additionally, donor eligibility determinations were made without complete screening and testing results, raising concerns about the safety of reproductive tissues.
View Company Profile
ID · 2ed791eb-dc48-403b-a814-9333ab17d997
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.